Explore how covalent topoisomerase II poisons weaponize essential DNA enzymes to create powerful cancer therapies and the scientific breakthroughs driving this field.
Discover how damaged DNA can actively sabotage the p53 cancer fighter, triggering a vicious cycle that may accelerate cancer and aging through DNA-mediated oxidation.
Discover how membrane steroid receptors are revolutionizing our understanding of hormone-sensitive cancers and opening new avenues for targeted treatments.
Discover how cross-species genomic research between humans and dogs is identifying novel driver genes in embryonal rhabdomyosarcoma, a devastating childhood cancer.
Discover how restoring wild-type p53 activity in p53-null HL-60 cells can re-sensitize them to chemotherapy and overcome drug resistance in cancer.
Discover how breakthroughs in eccDNA synthesis are revolutionizing cancer research and treatment possibilities.
Exploring how Aurora B kinase inhibition triggers cancer cell self-destruction through aneuploidy-induced p21 activation
How machine learning algorithms predict cancer cell sensitivity to natural products by decoding genomic and chemical blueprints